This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jalali, Z.
Right arrow Articles by Pirofski, L.-a.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jalali, Z.
Right arrow Articles by Pirofski, L.-a.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, July 2006, p. 740-746, Vol. 13, No. 7
1071-412X/06/$08.00+0     doi:10.1128/CVI.00139-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Antibody Response to Cryptococcus neoformans Capsular Polysaccharide Glucuronoxylomannan in Patients after Solid-Organ Transplantation

Ziba Jalali,1,{dagger} Lucky Ng,1,{ddagger} Nina Singh,3 and Liise-anne Pirofski1,2*

Division of Infectious Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York,1 Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York,2 Veterans Affairs Medical Center, Infectious Diseases Section, Pittsburgh, Pennsylvania3

Received 12 April 2006/ Returned for modification 15 May 2006/ Accepted 19 May 2006

Cryptococcosis is an important complication of solid-organ transplantation, but the risk factors for disease are poorly understood. The goal of this study was to investigate whether specific or nonspecific serum immunoglobulin levels determined in samples obtained before and after solid-organ transplantation differed in patients who did or did not develop cryptococcosis after transplantation. We analyzed pretransplantation sera from 25 subjects, 15 who subsequently developed cryptococcosis and 10 who did not, and posttransplantation sera from 24 subjects, 13 who developed cryptococcosis and 11 who did not. All subjects received a tacrolimus-based immunosuppressive regimen. Total immunoglobulin levels were measured by immunodiffusion, and Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan (GXM)-specific serum antibody levels were determined by enzyme-linked immunosorbent assays. The results showed that solid-organ transplantation had a significant effect on total immunoglobulin and GXM-reactive antibody levels. GXM-reactive antibody levels differed in subjects who did and did not develop cryptococcosis. In pretransplant serum samples, the levels of GXM-reactive immunoglobulin M (IgM) were significantly lower in subjects who developed cryptococcosis after transplantation than in those who did not. For posttransplant serum samples, the levels of GXM-reactive IgM and IgG were significantly higher among the subjects who developed cryptococcosis than among those who did not. These findings suggest that perturbations in the preexisting antibody or B-cell repertoire and/or related to treatment of rejection, transplantation, or immunosuppressive therapy could translate into an increased risk for transplant-associated cryptococcosis.

* Corresponding author. Mailing address: Division of Infectious Diseases, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461. Phone: (718) 430-2372. E-mail: pirofski{at}aecom.yu.edu.

{dagger} Present address: Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebr.

{ddagger} Present address: Yale University, New Haven, Conn.

Clinical and Vaccine Immunology, July 2006, p. 740-746, Vol. 13, No. 7
1071-412X/06/$08.00+0     doi:10.1128/CVI.00139-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Datta, K., Lees, A., Pirofski, L.-a. (2008). Therapeutic Efficacy of a Conjugate Vaccine Containing a Peptide Mimotope of Cryptococcal Capsular Polysaccharide Glucuronoxylomannan. CVI 15: 1176-1187 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»